| Medical Center For Joint Restoration And Regenerative Medicine, Llc | |
|
3900 S Walnut St Ste A Bloomington IN 47401-7331 | |
| (812) 822-1516 | |
| Not Available |
| Full Name | Medical Center For Joint Restoration And Regenerative Medicine, Llc |
|---|---|
| Speciality | Family Medicine |
| Location | 3900 S Walnut St Ste A, Bloomington, Indiana |
| Authorized Official Name and Position | Erika Esther Giron (OWNER) |
| Authorized Official Contact | 8128221516 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Medical Center For Joint Restoration And Regenerative Medicine, Llc 3900 S Walnut St Ste A Bloomington IN 47401-7331 Ph: (812) 822-1516 | Medical Center For Joint Restoration And Regenerative Medicine, Llc 3900 S Walnut St Ste A Bloomington IN 47401-7331 Ph: (812) 822-1516 |
| NPI Number | 1194316596 |
|---|---|
| Provider Enumeration Date | 01/28/2021 |
| Last Update Date | 06/29/2021 |
| Medicare PECOS PAC ID | 3779998695 |
|---|---|
| Medicare Enrollment ID | O20210226000335 |
News Archive
A team of researchers at the IRCM led by Dr. Andr- Veillette made an important breakthrough in the field of immunology, which will be published online today by the scientific journal Immunity. The scientists explained a poorly understood molecular mechanism associated with a human immune disorder known as XLP disease or Duncan's syndrome.
A compound found in green tea shows great promise for the development of drugs to treat two types of tumors and a deadly congenital disease. The discovery is the result of research led by Principal Investigator, Dr. Thomas Smith at The Donald Danforth Plant Science Center and his colleagues at The Children's Hospital of Philadelphia.
A new Harris Interactive poll shows a majority of American parents believe they, rather than the government, should have the final say in which vaccines their children receive.
Simvastatin, a commonly used, cholesterol-lowering drug, may prevent Parkinson's disease from progressing further. Neurological researchers at Rush University Medical Center conducted a study examining the use of the FDA-approved medication in mice with Parkinson's disease and found that the drug successfully reverses the biochemical, cellular and anatomical changes caused by the disease.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194316596 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| Provider Name | Debra Hermann |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1992345201 PECOS PAC ID: 1658786587 Enrollment ID: I20210226000425 |
News Archive
A team of researchers at the IRCM led by Dr. Andr- Veillette made an important breakthrough in the field of immunology, which will be published online today by the scientific journal Immunity. The scientists explained a poorly understood molecular mechanism associated with a human immune disorder known as XLP disease or Duncan's syndrome.
A compound found in green tea shows great promise for the development of drugs to treat two types of tumors and a deadly congenital disease. The discovery is the result of research led by Principal Investigator, Dr. Thomas Smith at The Donald Danforth Plant Science Center and his colleagues at The Children's Hospital of Philadelphia.
A new Harris Interactive poll shows a majority of American parents believe they, rather than the government, should have the final say in which vaccines their children receive.
Simvastatin, a commonly used, cholesterol-lowering drug, may prevent Parkinson's disease from progressing further. Neurological researchers at Rush University Medical Center conducted a study examining the use of the FDA-approved medication in mice with Parkinson's disease and found that the drug successfully reverses the biochemical, cellular and anatomical changes caused by the disease.
› Verified 6 days ago
| Provider Name | Liang Lu Miller |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1396316550 PECOS PAC ID: 3577961952 Enrollment ID: I20211015000980 |
News Archive
A team of researchers at the IRCM led by Dr. Andr- Veillette made an important breakthrough in the field of immunology, which will be published online today by the scientific journal Immunity. The scientists explained a poorly understood molecular mechanism associated with a human immune disorder known as XLP disease or Duncan's syndrome.
A compound found in green tea shows great promise for the development of drugs to treat two types of tumors and a deadly congenital disease. The discovery is the result of research led by Principal Investigator, Dr. Thomas Smith at The Donald Danforth Plant Science Center and his colleagues at The Children's Hospital of Philadelphia.
A new Harris Interactive poll shows a majority of American parents believe they, rather than the government, should have the final say in which vaccines their children receive.
Simvastatin, a commonly used, cholesterol-lowering drug, may prevent Parkinson's disease from progressing further. Neurological researchers at Rush University Medical Center conducted a study examining the use of the FDA-approved medication in mice with Parkinson's disease and found that the drug successfully reverses the biochemical, cellular and anatomical changes caused by the disease.
› Verified 6 days ago
News Archive
A team of researchers at the IRCM led by Dr. Andr- Veillette made an important breakthrough in the field of immunology, which will be published online today by the scientific journal Immunity. The scientists explained a poorly understood molecular mechanism associated with a human immune disorder known as XLP disease or Duncan's syndrome.
A compound found in green tea shows great promise for the development of drugs to treat two types of tumors and a deadly congenital disease. The discovery is the result of research led by Principal Investigator, Dr. Thomas Smith at The Donald Danforth Plant Science Center and his colleagues at The Children's Hospital of Philadelphia.
A new Harris Interactive poll shows a majority of American parents believe they, rather than the government, should have the final say in which vaccines their children receive.
Simvastatin, a commonly used, cholesterol-lowering drug, may prevent Parkinson's disease from progressing further. Neurological researchers at Rush University Medical Center conducted a study examining the use of the FDA-approved medication in mice with Parkinson's disease and found that the drug successfully reverses the biochemical, cellular and anatomical changes caused by the disease.
› Verified 6 days ago
Joie Devivre Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1535 Piazza Drive, Bloomington, IN 47401 Phone: 812-334-2772 | |
Drb Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2620 North Walnut Street, Suite 400, Bloomington, IN 47404 Phone: 812-335-1824 Fax: 812-335-1825 | |
Hoosier Wellness Providers, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 421 W 1st St, Bloomington, IN 47403 Phone: 561-635-2400 | |
Quest Integrative Health Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 353 S Landmark Ave, Bloomington, IN 47403 Phone: 812-330-1234 Fax: 812-330-1221 | |
Ilic Renal And Hypertension Associates, P.a. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 3825 E Devonshire Ct, Bloomington, IN 47408 Phone: 812-837-3223 | |
Healthspot Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3064 E 3rd St, Bloomington, IN 47401 Phone: 812-323-9800 | |
First Health Plus, Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 104 North Curry Pike, Bloomington, IN 47404 Phone: 812-339-9980 |